Argentina's ANMAT bans all products from two labs over quality control failures

Argentina's national drug and food regulator (ANMAT) has banned all products from two laboratories due to 'serious failures' and non-compliance, specifically citing deficiencies in quality controls. The ban is a regulatory enforcement action affecting the domestic market; the identities of the labs and the scope of affected products are not yet disclosed. This signals potential supply disruptions for those products and underscores regulatory tightening in Argentina's pharmaceutical sector.